When should high-grade heart block trigger a search for a treatable cardiomyopathy?

Circulation: Arrhythmia and Electrophysiology

Volumn 4, Issue 3, 2011, Pages 260-261

  Cooper Jr , Leslie T ^a   Blauwet, Lori A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cardiomyopathy; Editorials; Giant cells; Heart block; Myocarditis; Sarcoidosis

Indexed keywords

ATRIOVENTRICULAR BLOCK; CARDIAC SARCOIDOSIS; CARDIOVASCULAR MAGNETIC RESONANCE; CONGESTIVE HEART FAILURE; EDITORIAL; EPICARDIUM MAPPING; FOLLOW UP; HEART BLOCK; HEART BUNDLE BRANCH BLOCK; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; INTERSTITIAL MYOCARDITIS; MYOCARDITIS; PACEMAKER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SARCOIDOSIS; SYSTOLIC DYSFUNCTION; ADOLESCENT; ADULT; BIOPSY; ELECTROCARDIOGRAPHY; HEART MUSCLE; HEART PACING; HYPERTROPHIC CARDIOMYOPATHY; MIDDLE AGED; NOTE; PATHOLOGY;

ADOLESCENT; ADULT; BIOPSY; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, HYPERTROPHIC; ELECTROCARDIOGRAPHY; HEART BLOCK; HUMANS; MIDDLE AGED; MYOCARDIUM; YOUNG ADULT;

EID: 80052316124     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.111.963249     Document Type: Editorial

References (15)

1. Davidoff R, Palacios I, Southern J, Fallon JT, Newell J, Dec GW. Giant cell versus lymphocytic myocarditis: a comparison of their clinical features and long-term outcomes. Circulation. 1991;83:953-961.
2. Kim JS, Judson MA, Donnino R, Gold M, Cooper LT Jr, Prystowsky EN, Prystowsky S. Cardiac sarcoidosis. Am Heart J. 2009;157:9-21.
3. Okura Y, Dec GW, Hare JM, Kodama M, Berry GJ, Tazelaar HD, Bailey KR, Cooper LT. A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol. 2003;41:322-329.
4. Cooper LT Jr, Berry GJ, Shabetai R; Multicenter Giant Cell Myocarditis Study Group Investigators. Idiopathic giant-cell myocarditis-natural history and treatment. N Engl J Med. 1997;336:1860-1866.
5. Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE; Myocarditis Treatment Trial Investigators. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med. 1995;333:269-275.
6. Cooper LT Jr, Hare JM, Tazelaar HD, Edwards WD, Starling RC, Deng MC, Menon S, Mullen GM, Jaski B, Bailey KR, Cunningham MW, Dec GW; Giant Cell Myocarditis Treatment Trial Investigators. Usefulness of immunosuppression for giant cell myocarditis. Am J Cardiol. 2008;102: 1535-1539.
7. Yazaki Y, Isobe M, Hiroe M, Morimoto S, Hiramitsu S, Nakano T, Izumi T, Sekiguchi M. Central Japan Heart Study Group. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol. 2001;88:1006-1010. (Pubitemid 33042612)
8. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, Levine GN, Narula J, Starling RC, Towbin J, Virmani R; American Heart Association; American College of Cardiology; European Society of Cardiology; Heart Failure Society of America; Heart Failure Association of the European Society of Cardiology. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation. 2007;116: 2216-2233. (Pubitemid 350060359)
9. Uemura A, Morimoto S, Hiramitsu S, Hishida H. Endomyocardial biopsy findings in 50 patients with idiopathic atrioventricular block: presence of myocarditis. Jpn Heart J. 2001;42:691-700. (Pubitemid 34196177)
10. Kandolin R, Lehtonen J, Kupari M. Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults. Circ Arrhythm Electrophysiol. 2011;4:303-309.
11. Bresnitz EA, Strom BL. Epidemiology of sarcoidosis. Epidemiol Rev. 1983;5:124-156. (Pubitemid 14238316)
12. Schulz-Menger J, Wassmuth R, Abdel-Aty H, Siegel I, Franke A, Dietz R, Friedrich MG. Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance. Heart. 2006;92:399-400.
13. Vignaux O. Cardiac sarcoidosis: spectrum of MRI features. AJR Am J Roentgenol. 2005;184:249-254. (Pubitemid 40040938)
14. Okumura W, Iwasaki T, Toyama T, Iso T, Arai M, Oriuchi N, Endo K, Yokoyama T, Suzuki T, Kurabayashi M. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med. 2004;45: 989-998.
15. Ardehali H, Howard DL, Hariri A, Qasim A, Hare JM, Baughman KL, Kasper EK. A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy. Am Heart J. 2005;150:459-463. (Pubitemid 41317613)